Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin (BI 1356) Add-on to Metformin and Sulphonylurea in Type 2 Diabetes
NCT00602472Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Started Feb 2008; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00602472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00602472.